Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/4/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Thomas F. Deuel

Wrong Dr. Thomas F. Deuel?

Board Member

Phone: (732) ***-****  HQ Phone
Enzon Pharmaceuticals , Inc.
20 Kingsbridge Road
Piscataway, New Jersey 08854
United States

Company Description: Enzon Pharmaceuticals, Inc. (Enzon) is a biopharmaceutical company focused on developing, manufacturing and commercializing of medicines for patients with cancer...   more
Background

Employment History

  • Professor of Molecular and Experimental Medicine and Cell Biology, Director of the Division of Molecular Oncology, Department of Molecular and Experimental Medicine and Director of the Vascular Biology Affinity Group
    The Scripps Research Institute
  • President
    Edward R. Mallinckrodt Foundation
  • Professor of Medicine
    Harvard Medical School
  • Director, Division of Growth Regulation
    Beth Israel Hospital
  • Professor of Medicine and Biochemistry and the Head of Oncology Services
    Washington University School Of Medicine
  • Various Editorial Boards
    Journal Of Clinical Investigation And Blood

Board Memberships and Affiliations

Education

  • M.D.
    Columbia University
  • A.B. , Biology
    Princeton University
52 Total References
Web References
...
www.sec.gov, 4 Jan 2013 [cached]
0001405880 Deuel Thomas C/O ENZON PHARMACEUTICALS, INC. 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854 1 0 0 0
The Board has nominated and recommends ...
www.sec.gov, 6 April 2012 [cached]
The Board has nominated and recommends that the stockholders elect Alexander J. Denner, Richard C. Mulligan, Thomas F. Deuel, George W. Hebard III, Robert LeBuhn, Robert C. Salisbury and Richard A. Young for one-year terms.
...
Hebard, LeBuhn and Salisbury, Drs. Denner, Deuel and Young, and Professor Mulligan.
...
Thomas F. Deuel
...
Thomas F. Deuel, M.D. has served as a director of the Company since April 2010. Dr. Deuel is currently a Professor of Molecular and Experimental Medicine and Cell Biology, Director of the Division of Molecular Oncology, Department of Molecular and Experimental Medicine, and Director of the Vascular Biology Affinity Group at The Scripps Research Institute and has served in such positions since February 2002. In addition, since 1998, Dr. Deuel has served as a Professor of Medicine at Harvard Medical School, where he is currently a Professor Emeritus. From 1996 to 2002, Dr. Deuel served as a Director, Division of Growth Regulation at Beth Israel Hospital, Boston, Massachusetts and, prior to that, was a Professor of Medicine and Biochemistry and the head of Oncology Services at the Washington University School of Medicine, St. Louis, Missouri. Dr. Deuel is a member of the Institute of Medicine at the National Academy of Sciences. Dr. Deuel is also President of the Edward R. Mallinckrodt Foundation, St. Louis, Missouri. He has served on various editorial boards, including the Journal of Clinical Investigation and Blood, and currently is on the Editorial Board of Current Opinion in Hematology and Section Editor for Vascular Biology. Dr. Deuel has served and continues to serve on numerous scientific advisory boards for various companies, including the scientific advisory board of ImClone Systems Incorporated, a publicly-traded biopharmaceutical company, during the existence of such board (from 1988 to 2001). From July 2007 to November 2008, Dr. Deuel served on ImClone’s board of directors. Dr. Deuel has earned many professional honors and awards and holds an M.D. from Columbia University and an A.B. from Princeton University.
Dr. Deuel, a professor at both The Scripps Research Institute and Harvard Medical School, brings to the Board many years of experience with scientific and medical research, particularly in the areas of molecular medicine and oncology. A noted researcher, Dr. Deuel’s involvement in and connections with the academic and research communities provide the Board with a unique scientific perspective and key access to other scholars and researchers in the field.
Hatteras Venture Partners
www.hatterasvp.com, 29 Aug 2012 [cached]
Thomas Deuel, MD, discoverer of PDGF, cancer biology expert, member of Institute of Medicine at the National Academy of Sciences
Thomas F. Deuel, M.D., ...
www.sec.gov, 7 Aug 2008 [cached]
Thomas F. Deuel, M.D., Director
...
Dr. Deuel owned no shares of the Company's stock, nor did he have any options at June 30, 2008.
...
The Board of Directors, acting upon the unanimous recommendation of its Nominating and Corporate Governance Committee, has nominated Mr. John E. Celentano, Dr. Alexander J. Denner, Dr. Thomas F. Deuel, Mr. Jules Haimovitz, Mr. Carl C. Icahn, Mr. John H. Johnson, Dr. Peter S. Liebert, Dr. Richard C. Mulligan, Dr. David Sidransky and Dr. Charles Woler for election as directors at the Annual Meeting.
...
Thomas F. Deuel, M.D.(1)(2)
...
Thomas F. Deuel, M.D., has served as a director of the Company since July 3, 2007.Since February 2002, Dr. Deuel has served as a Professor of Molecular and Experimental Medicine and Cell Biology, Director of the Division of Molecular Oncology, Department of Molecular and Experimental Medicine, and Director of the Vascular Biology Affinity Group at The Scripps Research Institute.Also, since 1998, Dr. Deuel has served as a Professor of Medicine at Harvard Medical School.He is currently a Professor Emeritus at Harvard Medical School.In addition, from 1996 to 2002, Dr. Deuel served as a Director, Division of Growth Regulation at Beth Israel Hospital, Boston, Massachusetts and, prior to that, was a Professor of Medicine and Biochemistry and the head of Oncology Services at the Washington University School of Medicine, St. Louis, Missouri.He is a member of the Institute of Medicine at the National Academy of Sciences.Dr. Deuel is also President of the Edward R. Mallinckrodt Foundation, St. Louis, Missouri.He has served on different editorial boards, including the Journal of Clinical Investigation and Blood, and currently is on the Editorial Board of Current Opinion in Hematology and Section Editor for Vascular Biology.Dr. Deuel has served and continues to serve on numerous scientific advisory boards for various companies, including the Company's scientific advisory board during its existence.In addition, Dr. Deuel has earned many professional honors and awards.Dr. Deuel holds an M.D. from Columbia University and an A.B. from Princeton University.
...
(Chairman), Alexander J. Denner, Thomas F. Deuel, Jules Haimovitz and Carl C. Icahn.
...
Denner, Thomas F. Deuel, Richard C. Mulligan and Charles Woler.
...
www.sec.gov, 5 Jan 2012 [cached]
0001405880 Deuel Thomas C/O ENZON PHARMACEUTCALS, INC. 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854 1 0 0 0
Other People with the name "Deuel":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.